跳转至内容
Merck
CN

857341P

Avanti

VPC 12249 (S)

Avanti Research - A Croda Brand

别名:

[(2S)-2-[[(Z)-octadec-9-enoyl]amino]-3-(4-phenylmethoxyphenyl)propyl] hydrogen phosphate

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C34H55N2O6P
化学文摘社编号:
分子量:
618.78
UNSPSC Code:
12352211
NACRES:
NA.25
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

VPC 12249 (S), (S)-phosphoric acid mono-[3-(4-benzyloxy-phenyl)-2-octadec-9-enoylamino-propyl] ester (ammonium salt), powder

SMILES string

O=C(CCCCCCC/C=C\CCCCCCCC)N[C@H](COP(O)([O-])=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1.[NH4+]

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (857341P-1mg)

manufacturer/tradename

Avanti Research - A Croda Brand 857341P

lipid type

phospholipids
cardiolipins

shipped in

dry ice

storage temp.

−20°C

General description

VPC 12249 is an N-acyl (oleoyl) serine phosphate-based compound.

Application

VPC 12249 has been used as lysophosphatidic acid (LPA)1/3 receptor antagonist in various experimental studies.

Biochem/physiol Actions

Lysophosphatidic acids (LPAs) are bioactive lipid mediators. It interacts with at least six specific LPA receptors (LPA1-6) to mediate extracellular signaling pathway. LPA and its receptors (LPA1-3) are implicated in the pathogenesis of radiation pneumonitis (RP). VPC 12249 (S) inhibits the binding ofLPA to LPA1 and LPA3 receptor.

Packaging

5 mL Amber Glass Screw Cap Vial (857341P-1mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

13 - Non Combustible Solids

wgk

WGK 3

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yung, Y, et al.
Journal of Lipid Research, 55(7), 1192-1214 (2014)
Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling
Shlyonsky V, et al.
Pulmonary Circulation, 4(3), 471-481 (2014)
Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor
Hasegawa Y, et al.
The Journal of Biological Chemistry, 278(14), 11962-11969 (2003)
Effects of lysophosphatidic acid and its receptors LPA 1/3; on radiation pneumonitis
Xue J, et al.
Oncology Reports, 24(6), 1515-1520 (2010)
Lysophosphatidic acid inhibits insulin signaling in primary rat hepatocytes via the LPA3 receptor subtype and is increased in obesity
Fayyaz S, et al.
Cellular Physiology and Biochemistry, 43(2), 445-456 (2017)

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持